Published By : Prameya News Bureau | April 24, 2020 IST
Share
Varanasi, April 24: The Banaras Hindu University (BHU) wants to carry out a clinical trial of immunity-boosting ayurvedic drug 'Fifatrol' to check its efficacy in tackling the deadly COVID-19. However, the proposal is yet to be approved, official sources said. According to BHU professor and principal investigator for the proposed project, Dr K N Dwivedi, the plan has been sent to a task force formed by the government for scientific validation of Ayurveda and traditional medicinal formulas through research institutions in tackling COVID-19. The inter-disciplinary AYUSH Research and Development Task Force has members from the Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR) and also AYUSH practitioners and others. The scientists are trying to identify potential preventive therapy and therapeutic approaches from AYUSH systems in different stages of COVID-19 treatment. The AYUSH ministry had sought suggestions on various therapies, through a notification on March 31. The ministry asked Ayurveda, Yoga and naturopathy, Unani, Siddha and Homoeopathy (AYUSH) practitioners and institutions to submit their suggestions on various therapies, and has received over 2,000 proposals. According to experts, "Fifatrol, enriched with immune-enhancing herbs, has been found to be effective in curing major bacterial infections such as staphylococcus species that causes fever, cough and cold, and skin diseases among others. AIMIL Pharmaceuticals, the company that produces Fifatrol, said that drug is used to treat flu and viral infections of upper respiratory tract. But this is for the first time that experts have decided to determine if it can be helpful in combating the novel coronavirus. Dr Dwivedi, who is the head of the Department of Dravyaguna at BHU, said Fifatrol is given to patients with symptoms similar to COVID-19. "We are now trying to evaluate this drug on critically-ill COVID-19 patients to check if it can help reduce mortality," he said. He said that during a trial on dengue patients at AIIMS, Bhopal, the drug was found to have increased platelet count significantly. The study also established that Fifatrol can strengthen the liver with no systemic side effects. Fifatrol is an anti-microbial solution prepared from 13 key herbs including sudarshan vati, sanjeevani vati, godanti bhasma, tribhuvan kirti ras and mrityunjay ras, tulsi, kutki, chirayata, motha and giloy. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
India to become one of biggest semiconductor hubs in next 5 years: Vaishnaw
PM Modi advocates for resilient infrastructure at 39-nation meet on natural disasters
Supreme Court to issue directions on mandatory VVPAT verification
PM Modi to address public meetings in Chhattisgarh, MP today
DRDO develops India's lightest bulletproof jacket
Lok Sabha polls: NDA will sweep all 28 seats in K'taka, says Amit Shah
India carries out successful launch of medium-range ballistic missile's new version
Fire at Bandhwari landfill site raises concerns
EcoR to run 10 Summer Special trains in Odisha, Know details.....
Surat Congress leader Nilesh Kumbhani 'vanishes' amid election controversy
BJP dividing people in name of religion: Sharmila
More than 5 grams of artificial sweetener saccharin a day can be fatal: Doctors
PayU gets RBI's in-principle nod to operate as payments aggregator
Nagpur school management faces action in poll code violation complaint against Union Minister Gadkari
Time for Global South to assume greater role: EAM Jaishankar at ASEAN meet
Delhi HC restrains Lokpal from acting upon CBI probe into JMM properties linked to party chief Shibu Soren
78-year-old man swims from Sri Lanka to Rameswaram, dies
Don’t get provoked, think twice and vote for country, your development: Priyanka’s appeal to K'taka voters
Museum on Indo-France culture to be set-up in Delhi
Apple ecosystem is one of the leading employment generators in India: Vaishnaw